| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $-0.12 (Beat by $0.54) |
| EPS GAAP Actual | $-0.12 (Beat by $0.54) |
| Revenue Actual | $0.143556B |
| Revenue Surprise | Beat by $143.556M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.02 |
| EPS GAAP Estimate | $-0.02 |
| Revenue Estimate | $0.2193175B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0502 | 0.7102 | 0.143556B | -3.37% | -2.69M |
| FQ2 2025 (Jun 2025) | -0.11 | -0.11 | 0.179077B | -4.75% | 9.56M |
| FQ1 2025 (Mar 2025) | 0.2 | 0.2 | 0.21582B | -1.51% | 11.06M |
| FQ4 2024 (Dec 2024) | -0.32 | -0.32 | 0.17334B | -2.42% | 0.45M |
| FQ3 2024 (Sep 2024) | 0.57 | 1.05 | 0.148398B | -7.68% | -6.27M |
| FQ2 2024 (Jun 2024) | -0.17 | 0.04719 | 0.187587B | 0.47% | -3.21M |
| FQ1 2024 (Mar 2024) | 0.28 | 0.363846 | 0.219079B | 100% | 8.38M |
| FQ3 2012 (Sep 2012) | 0 | 0 | 0.054043B | 100% | 54.04M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.02
Consensus Revenue Estimates
0.2193175B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.44 | -- | -0.44879 | -0.43121 | 1 |
| FQ3 2026 (Sep 2026) | -0.6 | 108.37 | -0.62605 | -0.57395 | 1 |
| FQ2 2026 (Jun 2026) | -0.41 | 73.17 | -0.4278 | -0.3922 | 1 |
| FQ1 2026 (Mar 2026) | -0.02 | 1100 | -0.02039939 | -0.01960061 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.18B | -- | 0.17B | 0.18B | 1 |
| FQ3 2026 (Sep 2026) | 0.15B | 4.68 | 0.15B | 0.16B | 1 |
| FQ2 2026 (Jun 2026) | 0.18B | -1.27 | 0.17B | 0.18B | 1 |
| FQ1 2026 (Mar 2026) | 0.22B | 1.59 | 0.22B | 0.22B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.66 | 0.0502 | 0.7102 | 1414.74% |
| FQ2 2025 (Jun 2025) | 0 | -0.11 | -0.11 | 100% |
| FQ1 2025 (Mar 2025) | 0 | 0.2 | 0.2 | 100% |
| FQ4 2024 (Dec 2024) | 0 | -0.32 | -0.32 | 100% |
| FQ3 2024 (Sep 2024) | -0.48 | 0.57 | 1.05 | 184.21% |
| FQ2 2024 (Jun 2024) | -0.21719 | -0.17 | 0.04719 | -27.76% |
| FQ1 2024 (Mar 2024) | -0.083846 | 0.28 | 0.363846 | 129.95% |
| FQ3 2012 (Sep 2012) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.15B | $0.14B | $-2.69M | -1.87% |
| FQ2 2025 (Jun 2025) | $0.17B | $0.18B | $9.56M | 5.34% |
| FQ1 2025 (Mar 2025) | $0.2B | $0.22B | $11.06M | 5.13% |
| FQ4 2024 (Dec 2024) | $0.17B | $0.17B | $0.45M | 0.26% |
| FQ3 2024 (Sep 2024) | $0.15B | $0.15B | $-6.27M | -4.23% |
| FQ2 2024 (Jun 2024) | $0.19B | $0.19B | $-3.21M | -1.71% |
| FQ1 2024 (Mar 2024) | $0.21B | $0.22B | $8.38M | 3.82% |
| FQ3 2012 (Sep 2012) | $0B | $0.05B | $54.04M | 100% |